Neotract

About:

NeoTract develops surgical devices for urological and gynecological disorders.

Twitter/X: neotract

Top Investors: New Enterprise Associates, ExploraMed, Greenspring Associates, Quadrille Capital, Windham Venture Partners

Description:

NeoTract, Inc. develops surgical devices for urological and gynecological disorders.

Total Funding Amount:

$176M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Mountain View, California, United States

Founded Date:

2004-01-01

Founders:

Joseph Catanese, Josh Makower, Ted Lamson

Number of Employees:

251-500

Last Funding Date:

2017-01-01

IPO Status:

Private

Industries: